Vaxart, Inc. (VXRT) stock
VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026Market cap $115.61MP/E 4.0Yield –
Vaxart profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Vaxart's profit margin for the twelve months ending Sep 30, 2026 was 16.0%. For fiscal 2025 it was 6.9%, against -233.3% the year before. The highest annual figure on record is 6.9% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.9% | +240.1 |
| FY2024 | Dec 31, 2024 | -233.3% | +884.3 |
| FY2023 | Dec 31, 2023 | -1117.6% | +99590.8 |
| FY2022 | Dec 31, 2022 | -100708.4% | −92808.2 |
| FY2021 | Dec 31, 2021 | -7900.2% | −7103.9 |
| FY2020 | Dec 31, 2020 | -796.3% | −607.3 |
| FY2019 | Dec 31, 2019 | -189.1% | +243.9 |
| FY2018 | Dec 31, 2018 | -433.0% | −159.8 |
| FY2016 | Jun 30, 2016 | -273.1% | −195.5 |
| FY2015 | Jun 30, 2015 | -77.6% | −61.6 |
| FY2014 | Jun 30, 2014 | -16.0% | +10.5 |
| FY2013 | Jun 30, 2013 | -26.5% | +67.6 |
| FY2012 | Jun 30, 2012 | -94.1% | +84.4 |
| FY2009 | Dec 26, 2009 | -178.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -166.6% | −155.3 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -49.6% | −11.9 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 13.2% | +87.9 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 52.8% | +131.7 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -11.2% | +274.2 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -37.7% | +219.5 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -74.7% | +1044.8 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -78.9% | +456.5 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -285.4% | +542.8 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -257.2% | +1403.3 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -1119.5% | +2604.9 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -535.4% | +108182.7 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -828.2% | +28702.4 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -1660.5% | +26398.9 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -3724.4% | +5067.1 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -108718.2% | −94328.9 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -29530.6% | −26367.1 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -28059.5% | −24165.9 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -8791.5% | −5740.6 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -14389.3% | −12672.8 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -3163.4% | −3118.7 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -3893.5% | −3729.9 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -3050.9% | −1892.4 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -1716.4% | +4915.3 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -44.7% | −19.9 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -163.7% | +113.8 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -1158.6% | +1171.7 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -6631.8% | −5172.7 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -24.8% | −178.7 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -277.4% | +905.9 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -2330.2% | −2232.1 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -1459.0% | −1076.7 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | 154.0% | +542.2 |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -1183.3% | −698.0 |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -98.1% | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -382.4% | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -388.2% | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -485.4% | – |
See a number that looks wrong?